Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180,200 | 182,800 | 151,300 | 167,100 | 189,200 |
| Receivables | 129,300 | 127,100 | 130,200 | 133,700 | 122,800 |
| Inventories | 141,500 | 142,100 | 148,900 | 139,000 | 135,000 |
| Income taxes - deferred | 26,800 | 21,800 | 29,200 | 30,600 | 24,700 |
| Other current assets | 0 | 32,100 | 0 | 0 | 0 |
| TOTAL | $542,100 | $531,600 | $524,900 | $542,300 | $526,100 |
| Non-Current Assets | |||||
| PPE Net | 216,700 | 213,000 | 211,500 | 205,700 | 199,200 |
| Investments And Advances | 22,200 | 20,200 | 14,300 | 16,000 | 14,000 |
| Intangibles | 446,600 | 453,800 | 460,900 | 465,200 | 471,000 |
| Other Non-Current Assets | 21,600 | 28,200 | 28,700 | 30,000 | 29,200 |
| TOTAL | $707,100 | $715,200 | $715,400 | $716,900 | $713,400 |
| Total Assets | $1,249,200 | $1,246,800 | $1,240,300 | $1,259,200 | $1,239,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 179,400 | 48,900 | 227,500 | 226,500 | 196,500 |
| Accrued Expenses | N/A | 140,300 | N/A | N/A | N/A |
| TOTAL | $179,400 | $226,200 | $227,500 | $226,500 | $196,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 224,500 | 235,900 | 253,000 | 279,600 | 288,800 |
| Other Non-Current Liabilities | 60,300 | 35,300 | 31,900 | 30,700 | 30,700 |
| TOTAL | $284,800 | $271,200 | $284,900 | $310,300 | $319,500 |
| Total Liabilities | $464,200 | $497,400 | $512,400 | $536,800 | $516,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 691,571 | 694,591 | 694,724 | 700,809 | 707,388 |
| Common Shares | 67,600 | 67,000 | 66,700 | 66,300 | 65,900 |
| Retained earnings | 468,800 | 433,900 | 413,200 | 385,400 | 349,300 |
| Other shareholders' equity | -14,000 | -16,200 | -18,900 | -20,800 | -19,500 |
| TOTAL | $785,000 | $749,400 | $727,900 | $722,400 | $723,500 |
| Total Liabilities And Equity | $1,249,200 | $1,246,800 | $1,240,300 | $1,259,200 | $1,239,500 |